AbCellera Biologics Inc. (ABCL)
2.78
-0.22 (-7.33%)
At close: Jan 14, 2025, 3:59 PM
2.85
2.52%
Pre-market Jan 15, 2025, 08:35 AM EST
Company Description
AbCellera Biologics Inc. develops antibody discovery platform.
Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs.
As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners.
AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company.
The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
AbCellera Biologics Inc.
| Country | CA |
| IPO Date | Dec 11, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 586 |
| CEO | Dr. Carl L.G. Hansen Ph.D. |
Contact Details
Address: 2215 Yukon Street Vancouver, BC CA | |
| Website | https://www.abcellera.com |
Stock Details
| Ticker Symbol | ABCL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001703057 |
| CUSIP Number | 00288U106 |
| ISIN Number | CA00288U1066 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Carl L.G. Hansen Ph.D. | Chief Executive Officer, President & Chairperson |
| Andrew Booth M.B.A. | Chief Financial Officer |
| Dr. Ester Falconer Ph.D. | Chief Technology Officer |
| Dr. Veronique Lecault Ph.D. | Chief Operating Officer & Director |
| Tryn T. Stimart Esq., J.D., M.Sc. | Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer |
| Graham Craig M.Sc. | Director of Corporate Development |
| Marcie Thiessen CPA, CGA | Senior Director of Finance & Accounting |
| Murray McCutcheon Ph.D. | Senior Vice President of Partnering |
| Neil Aubuchon B.A., M.B.A. | Chief Commercial Officer |
| Tiffany Chiu B.Sc., Ph.D. | Vice President of Communications |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 03, 2025 | 4 | Filing |
| Jan 03, 2025 | 4 | Filing |
| Jan 03, 2025 | 4 | Filing |
| Jan 03, 2025 | 4 | Filing |
| Dec 05, 2024 | 4 | Filing |
| Nov 26, 2024 | 4 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 04, 2024 | 10-Q | Quarterly Report |
| Nov 04, 2024 | 8-K | Current Report |
| Oct 09, 2024 | SCHEDULE 13G/A | [Amend] Filing |